CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale President & CEO sold 16,700 shares at an average $58.59 ($978,480)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $60.88 ($449,697)
- 4 Open-market sale President & CEO sold 16,700 shares at an average $55.71 ($930,276)
- 4/A Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $61.97 ($457,772)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale President & CEO sold 16,700 shares at an average $57.63 ($962,433)
- 4 Open-market sale Chief Medical Officer sold 7,387 shares at an average $59.43 ($438,978)
Page 17 of 22 · 421 filings